Skip to main content

Table 1 Baseline characteristics of patients with COVID-19

From: Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study

 

LPV/r group (n = 22)

Combination group (n = 19)

P-value

Age, year (mean ± SD)

62.0 ± 9.4

56.2 ± 9.7

0.058

Male, n (%)

8 (36)

10 (53)

0.295

Days from symptom onset to hospital admission (mean ± SD)

11 ± 6.8

12 ± 7.3

0.214

Coexisting medical conditions, n (%)

 Hypertension

5 (22.7)

4 (21.1)

1.000

 Diabetes

5 (22.7)

6 (31.6)

0.524

 Hepatitis

1 (4.5)

0 (0)

1.000

 Malignancy

1 (4.5)

2 (10.5)

0.895

Symptoms, n (%)

 Cough

13 (59)

10 (52.6)

0.678

 Shortness of breath

6 (27.3)

4 (21.1)

0.922

 Pharyngalgia

2 (9)

4 (21.1)

0.524

 Arthralgia/myalgia

7 (31.8)

4 (21.1)

0.438

 Chest pain

4 (18.2)

2 (10.5)

0.804

 Fatigue

7 (31.8)

9 (47.4)

0.309